Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NEXT Oncology
San Antonio, Texas, United Statesnextoncology.com ↗
- Ownership
- Private
- Employees
- ~102
- Development stage
- Phase 1
01
Overview
NEXT Oncology specializes in early-phase clinical trials for anticancer agents, focusing on providing advanced cancer patients with access to the latest investigational therapies. The company is recognized for its expertise in Phase 1 oncology research and has ongoing trials involving small molecules and monoclonal antibodies targeting solid tumors. Notable programs include HPK1 inhibitors and CSF-1R antagonists, both currently in Phase 1 development.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibody
- Industry
- Contract Research Organization
02
Partnerships
Crown Bioscience – exclusive partnership to expand translational oncology platforms and patient model developmentTexas Oncology – clinical collaboration as part of a large U.S. private oncology networkUS Oncology Network affiliation via Texas Oncology
Beyond the preview
Go deeper on NEXT Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NEXT Oncology.